Yan Sun

Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial

Vincent A. Miller, Vera Hirsh, Jacques Cadranel et al. · The Lancet Oncology · 2012 · 953 citations

Medicine, Oncology, Pharmacology +10

Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non–Small Cell Lung Cancer

Baohui Han, Kai Li, Qiming Wang et al. · JAMA Oncology · 2018 · 620 citations · Full text

Medicine, Oncology, Pharmacology +17

Optimal achieved blood pressure in acute intracerebral hemorrhage

Hisatomi Arima, Emma Heeley, Candice Delcourt et al. · Neurology · 2015 · 136 citations · Full text

Medicine, Neurology, Pharmacology +15

Impaired angiogenesis in aminopeptidase N-null mice

Roberto Rangel, Yan Sun, Liliana Guzman‐Rojas et al. · Proceedings of the National Academy of Sciences · 2007 · 127 citations · Full text

Medicine, Cell Biology, Molecular Biology +13

Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including <i>VEGFA</i>, in human osteosarcoma

Jilong Yang, Da Yang, Yan Sun et al. · Cancer · 2011 · 121 citations · Full text

Medicine, Genetics, Oncology +16